https://wikimd.com/index.php?action=history&feed=atom&title=Vecuronium_bromide 2026-04-24T12:44:39Z Revision history for this page on the wiki MediaWiki 1.44.2 https://wikimd.com/index.php?title=Vecuronium_bromide&diff=5641946&oldid=prev 2024-04-21T14:39:11Z

<p>CSV import</p> <p><b>New page</b></p><div>[[File:Vecuronium_bromide.svg|Vecuronium bromide|thumb]] &#039;&#039;&#039;Vecuronium bromide&#039;&#039;&#039; is a [[muscle relaxant]] used in [[anesthesia]] to facilitate [[endotracheal intubation]] and to provide skeletal muscle relaxation during surgery or mechanical ventilation. It is a non-depolarizing neuromuscular blocking agent of intermediate duration. Vecuronium bromide works by competing with [[acetylcholine]] for receptors at the [[neuromuscular junction]], leading to muscle relaxation. It is often preferred in patients with cardiovascular problems due to its minimal effects on heart rate and blood pressure.<br /> <br /> == Pharmacology ==<br /> Vecuronium bromide acts by binding competitively to the nicotinic [[acetylcholine receptor]]s at the neuromuscular junction, inhibiting acetylcholine from binding and thus preventing muscle contraction. Its action is reversed by acetylcholinesterase inhibitors, such as [[neostigmine]], which increase the concentration of acetylcholine at the neuromuscular junction.<br /> <br /> == Indications ==<br /> Vecuronium bromide is indicated for use as an adjunct to general [[anesthesia]] to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. It is also used in the ICU setting for managing patients requiring mechanical ventilation.<br /> <br /> == Dosage and Administration ==<br /> The dosage of vecuronium bromide varies based on the patient&#039;s weight, the desired degree of muscle relaxation, and the method of administration. It is typically administered intravenously, and its effects are seen within 2 to 3 minutes of administration.<br /> <br /> == Side Effects ==<br /> Common side effects of vecuronium bromide include:<br /> * Skin flushing<br /> * Hypotension<br /> * Tachycardia<br /> * Bronchospasm<br /> * Anaphylaxis (rare)<br /> <br /> Prolonged use of vecuronium bromide can lead to muscle weakness and myopathy, especially in critically ill patients.<br /> <br /> == Contraindications ==<br /> Vecuronium bromide is contraindicated in patients with known hypersensitivity to the drug. Caution is advised in patients with neuromuscular diseases such as [[myasthenia gravis]], as the effects of vecuronium may be profoundly increased in these individuals.<br /> <br /> == Pharmacokinetics ==<br /> Vecuronium bromide is metabolized in the liver and excreted by the kidneys. Its elimination half-life is approximately 65 to 75 minutes, but this can be prolonged in patients with hepatic or renal impairment.<br /> <br /> == History ==<br /> Vecuronium bromide was introduced in the 1980s as a safer alternative to older neuromuscular blocking agents. It quickly gained popularity due to its favorable pharmacokinetic profile and minimal cardiovascular effects.<br /> <br /> == See Also ==<br /> * [[Neuromuscular-blocking drug]]<br /> * [[Anesthesia]]<br /> * [[Acetylcholine receptor]]<br /> <br /> [[Category:Muscle relaxants]]<br /> [[Category:Anesthesia]]<br /> {{medicine-stub}}</div>

Prab